Supplementary table error prompts correction in kidney fibrosis paper
A Kidney International corrigendum has corrected a publication error in the article “Increased Smoothened signaling promotes kidney fibrosis through inhibiting autophagy in fibroblasts.” The journal and authors identified that an outdated version of Supplementary Table S1 had been uploaded during submission, and the table carried a compilation problem that merged the columns containing patients’ pathological grading or isotypes information with chronic kidney disease G-staging data. The result was a display anomaly in the affected supplementary file, not a reinterpretation of the study’s biological premise.
The correction is narrow, but it matters in a field where supplementary material often carries the clinical granularity needed to interpret translational nephrology studies. When pathology grades and CKD stage data are placed side by side, even a formatting failure can blur the relationship between tissue injury and clinical severity. For investigators studying kidney fibrosis, clarity in those data structures is not cosmetic; it is part of how readers judge whether experimental signaling pathways align with patient-level disease patterns.
Why the corrected table matters in a fibrosis paper
The parent article centers on Smoothened signaling, autophagy suppression in fibroblasts, and fibrotic remodeling in the kidney. In that setting, supplementary tables often function as the bridge between mechanism and clinic. Pathological grading can frame how much structural damage is present in tissue samples, while CKD G-staging anchors those findings to renal function and chronic disease burden. When those columns are merged incorrectly, the table stops serving as a reliable map between biology and phenotype.
Fibrosis research depends on precise phenotyping because the disease itself is the end result of layered processes: persistent injury, fibroblast activation, extracellular matrix deposition, and failure of normal repair pathways. Autophagy has a central housekeeping role in cell stress responses, and its inhibition in fibroblasts fits a plausible profibrotic model. If a supplementary table is meant to catalog the patient or tissue context surrounding those findings, an editing error can create confusion about which clinical samples correspond to which pathologic stage. Readers evaluating translational relevance need that distinction to remain intact.
The correction does not add new experimental results, and it does not change the stated biologic theme of the paper. It does, however, restore the structural integrity of the supplementary material. In a journal article dealing with kidney pathology, even a formatting error can affect how other investigators extract data, compare cohorts, or cite the work in future mechanistic studies.
Data integrity and the downstream impact of a table merge
Supplementary Table S1 appears to have contained two separate categories of information: pathological grading or isotypes information and chronic kidney disease G-staging data. Those are not interchangeable fields. Pathologic grading describes tissue-level severity or histologic classification, while G-staging reflects kidney function based on estimated glomerular filtration categories. Merging them can make a dataset harder to audit and may obscure the clinical context that gives experimental observations their meaning.
For nephrology researchers, a table error like this can be more disruptive than it looks at first glance. Translational kidney studies often rely on close reading of supplementary files to understand sample composition, severity distribution, and whether the mechanistic signal observed in fibroblasts corresponds to clinically advanced disease. A merged table can force the reader to guess where one variable ends and another begins, which is exactly the kind of ambiguity that can undermine confidence in otherwise carefully constructed work.
This is especially relevant in fibrotic disease, where staging informs interpretation. A cohort dominated by advanced CKD behaves differently from one enriched for earlier-stage disease, and histologic grading may track imperfectly with function. Preserving those categories separately helps readers assess whether the observed autophagy inhibition signal might be tied to more severe structural disease, a particular pathological subgroup, or a broader fibrotic process.
The correction also reflects a familiar reality in academic publishing: supplementary materials are often assembled under time pressure, and version control failures can slip through despite peer review and editorial checks. In experimental nephrology, the supplementary file is not an afterthought. It may contain the very sample annotations that let outside readers reconstruct the logic of the study.
What the corrigendum does and does not change
This corrigendum addresses a document-level error, not a scientific retraction or a revision of the article’s central claims. The paper’s core message remains the same: Increased Smoothened signaling promotes kidney fibrosis through inhibition of autophagy in fibroblasts. The correction simply clarifies that one supplementary table was not the intended final version and that its internal columns were compromised during compilation.
In practical terms, the corrigendum protects the fidelity of the published record. Researchers who return to the paper for reference can now distinguish the corrected supplementary data from the flawed upload. That matters for citation accuracy, data extraction, and any later attempt to synthesize this work with other kidney fibrosis studies that use human pathology and CKD staging as contextual variables.
A one-table correction may sound minor, yet publication integrity depends on exactly these fixes. Small inconsistencies accumulate quickly when a field is building translational evidence from cell biology, pathology, and clinical staging. Keeping the supplementary record clean is part of keeping the mechanistic record usable.
The publication record in kidney fibrosis research
Kidney fibrosis remains one of the central pathways to progressive renal decline, and investigators continue to link signaling pathways with fibroblast behavior in search of therapeutic entry points. In that setting, even editorial mistakes can become obstacles if they affect how data are interpreted across bench and bedside. A corrected table helps preserve the chain of evidence from pathological grading to CKD staging to mechanistic inference.
The corrigendum leaves readers with a simple but important takeaway: the supplemental file needed repair because two separate data domains were merged in error, and the journal has now acknowledged and corrected the problem. No new sample sizes, endpoints, or effect estimates were introduced in the correction, and none should be inferred from it. The clinical and mechanistic claims remain where they were, but the supporting table now matches the intended record.